We also now know that under placebo-controlled conditions, #cannabidiol (#CBD) improves outcomes in patients with schizophrenia when given as an adjunct med, showing that cannabinoids (not necessarily cannabis) improve symptoms.
https://www.ncbi.nlm.nih.gov/pubmed/29241357